Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Introduction Many controversies exist in the diagnosis and management of this aggressively
malignant condition, mainly because of limited literature and lack of randomized control …

Abstract The World Health Organization recently published the 4th edition of the
Classification of Head and Neck Tumors, including several new entities, emerging entities …

Abstract Objectives/Hypothesis: This study reviews the published outcomes related to
surgical (open, endoscopic, and endoscopic‐assisted) and nonsurgical treatment for …

Introduction Malignant sinonasal tumors comprise less than 1% of all neoplasms. A wide
variety of tumors occurring primarily in this site can present with an undifferentiated or poorly …

Esthesioneuroblastoma (ENB) is derived from the specialized olfactory neuroepithelium.
Hyams grading and Kadish staging have been used to prognosticate and to guide treatment …

Objectives/Hypothesis Olfactory neuroblastoma (ONB) is a rare sinonasal malignant
neoplasm that is known to develop late recurrence. The aim of this study is to evaluate the …

Esthesioneuroblastoma (ENB) was first described by Berger and Richard in 1924. 1 It has
been characterized as a rare malignant neoplasm of the sinonasal cavity that arises in the …

Background Esthesioneuroblastoma is a rare cancer of the anterior cranial base that arises
in the region of the olfactory rootlets. The purpose of this study was to review the long‐term …

Neuroendocrine neoplasms of the sinonasal region, which are relatively uncommon but
clinically very important, are reviewed here in the light of current knowledge. Using a …